Precision medicine aims to tailor treatments based on the genetic profile of a patient's tumor, but several challenges impede its full potential. Genomic sequencing is costly and not widely accessible. Even when sequencing is available, the interpretation of complex genetic data requires advanced bioinformatics tools and expertise, which are not universally available. Moreover, not all genetic mutations have corresponding targeted therapies, limiting treatment options.
